Changes in antihypertensive treatment in surviving patients SARS-CoV-2 respiratory infection and its cardiovascular impact after one year of follow-up

Med Clin (Barc). 2022 Feb 25;158(4):196-197. doi: 10.1016/j.medcli.2021.06.001. Epub 2021 Jun 16.

[Article in English, Spanish]

Authors

Daniel Águila Gordo¹, Jorge Martínez Del Rio², Jesús Piqueras Flores²

Affiliations

¹ Servicio de Cardiología, Hospital General Universitario de Ciudad Real, Ciudad Real, España. Electronic address: [email protected].
² Servicio de Cardiología, Hospital General Universitario de Ciudad Real, Ciudad Real, España.

No abstract available

Publication types

Letter

MeSH terms

Antihypertensive Agents / therapeutic use
COVID-19*
Cardiovascular System*
Follow-Up Studies
Humans
SARS-CoV-2

Substances

Antihypertensive Agents